首页> 外文期刊>World Journal of Gastroenterology >Detection of YMDD mutants using universal template real-time PCR.
【24h】

Detection of YMDD mutants using universal template real-time PCR.

机译:使用通用模板实时PCR检测YMDD突变体。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To establish a rapid and accurate method for the detection of lamivudine-resistant mutations in hepatitis B virus and monitor of lamivudine resistance during lamivudine treatment in patients with chronic hepatitis B virus infection. METHODS: We established a real-time PCR method using a universal template and TaqMan probe to detect YMDD mutants. Variants of YVDD and YIDD were tested by individual reactions (reaction V and reaction I) and total hepatitis B viruses were detected in another reaction for control (reaction C). Results were determined by deltaCt < 3.5 (deltaCt = Ct of reaction V or I - Ct of reaction C). Clones of the HBV polymerase gene containing different YMDD mutations were tested. Serum samples from 163 lamivudine-treated patients with chronic hepatitis B virus infection were detected using this method and the results were confirmed by DNA sequencing. RESULTS: As many as 1000 copies per milliliter of wide-type plasmid were detected and nonspecific priming was excluded. In the 163 samples from patients treated with lamivudine, lamivudine-resistant mutations were detected in 51 samples. CONCLUSION: This universal real-time PCR is a rapid and accurate method for quantification of YMDD mutants of HBV virus in lamivudine-treated patients and can be used to monitor lamivudine-resistant mutations before and during lamivudine therapy.
机译:目的:建立一种快速,准确的方法来检测慢性乙型肝炎病毒感染患者的拉米夫定耐药性突变并监测拉米夫定治疗期间对拉米夫定的耐药性。方法:我们建立了一个实时PCR方法,使用通用模板和TaqMan探针检测YMDD突变体。通过单独的反应(反应V和反应I)测试了YVDD和YIDD的变异,并在另一个反应中检测到了乙型肝炎病毒总量(反应C)。通过deltaCt <3.5来确定结果(deltaCt =反应V的Ct或反应C的I-Ct)。测试了包含不同YMDD突变的HBV聚合酶基因的克隆。使用这种方法检测了163例接受拉米夫定治疗的慢性乙型肝炎病毒感染患者的血清样品,并通过DNA测序证实了结果。结果:每毫升宽型质粒可检测多达1000个拷贝,并且排除了非特异性引物。在来自接受拉米夫定治疗的患者的163个样品中,在51个样品中检测到了拉米夫定耐药性突变。结论:这种通用的实时荧光定量PCR是一种快速,准确的方法,用于定量拉米夫定治疗患者的HBV病毒YMDD突变体,可用于监测拉米夫定治疗前后的拉米夫定耐药性突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号